(NASDAQ: HOLX) Hologic's forecast annual revenue growth rate of 5.18% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 7.9%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 11.75%.
Hologic's revenue in 2025 is $4,038,900,000.On average, 6 Wall Street analysts forecast HOLX's revenue for 2026 to be $947,248,134,953, with the lowest HOLX revenue forecast at $940,878,046,716, and the highest HOLX revenue forecast at $951,402,927,141. On average, 5 Wall Street analysts forecast HOLX's revenue for 2027 to be $995,745,324,877, with the lowest HOLX revenue forecast at $982,759,597,517, and the highest HOLX revenue forecast at $1,005,688,801,298.
In 2028, HOLX is forecast to generate $1,046,571,689,523 in revenue, with the lowest revenue forecast at $1,046,571,689,523 and the highest revenue forecast at $1,046,571,689,523.